课题基金 / 基金详情

项目摘要

项目成果

LINGCHONG YOU的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 一种分析细菌程序性死亡进化的合成生物学方法通常与细菌对应激条件的反应有关,如饥饿、竞争对手的存在和抗生素治疗。由于死亡对其参与者没有任何好处,程序性细菌死亡的进化是生物学中一个基本的、尚未解决的问题。一种流行的解释是,死亡是“利他主义”的:它可以为幸存者提供直接或间接的好处。换句话说,死亡可能代表了合作的终极形式。通过这一假设,可以在公益合作的大框架下对程序性死亡的演化进行分析。利用这一框架,研究表明各种细菌病原体的死亡可能导致公共产品。然而,在对微生物社会行为,特别是程序性细菌死亡的明确理解方面,仍然存在着根本的差距。事实上,利他主义死亡的优势从未在实验系统中得到明确证明。解决这一问题的一大挑战是自然生物过程的复杂性,其中许多混杂因素模糊了对与死亡相关的益处的解释和定量分析。例如,之前的工作受到了批评,因为涉及的基因操作导致了多种影响,因此很难区分不同的健康结果。这些问题使得研究结果可以有其他解释,比如PCD代表了对压力的不适应反应。我们建议结合使用合成生物学技术和微流控技术来克服这些限制。特别是,利用大肠杆菌中一组合成的基因电路来实现可调的利他死亡,我们将定量地定义利他死亡在种群水平上变得有利的条件,并考察它们在欺骗存在的情况下的进化动力学。为了进行这样的分析,我们将开发一个新的基于液滴的平台来研究不同条件下的进化动力学。在这种理解的基础上,我们将开发和评估利用进化动态的新治疗策略。我们的愿景是,拟议的研究 将产生几个广泛的影响。首先,它将填补我们对程序性死亡进化理解中的关键概念空白。其次,它将对细菌如何应对抗生素介导的压力产生新的见解,这对设计针对细菌病原体的新治疗策略具有重要意义。
英文摘要
DESCRIPTION (provided by applicant): A synthetic biology approach to analyze evolution of programmed bacterial death Programmed death is commonly associated with a bacterial response to stressful conditions, such as starvation, presence of competitors, and antibiotic treatment. As death offers no benefit to its actor, evolution of programmed bacterial death is a fundamental, unresolved problem in biology. A popular explanation is that the death is "altruistic": it can provide direct or indirect benefitsto the survivors. In other words, death may represent the ultimate form of cooperation. By making this assumption, evolution of programmed death can be analyzed under the general framework of public-good cooperation. Using this framework, studies have suggested possible public goods resulting from death in various bacterial pathogens. However, there remains a fundamental gap in the definitive understanding of microbial social behavior in general and programmed bacterial death in particular. Indeed, advantage of altruistic death has never been unequivocally demonstrated in an experimental system. A major challenge in tackling this problem is the complexity of natural biological processes, where numerous confounding factors obscure interpretation and quantitative analysis of the benefits associated with death. For example, previous work has been criticized because gene manipulations involved led to multiple effects and so it is hard to tease apart different fitness consequences. These issues make the results open to alternative explanations, such as PCD representing a maladaptive response to stress. We propose to use a combination of synthetic-biology techniques and microfluidics to overcome these limitations. In particular, using a set of synthetic gene circuits in bacterium Escherichia coli to implement tunable altruistic death, we will quantitatively define the condition under which altruistic death can become advantageous at the population level and examine their evolutionary dynamics in the presence of cheating. To enable such analysis, we will develop a novel droplet-based platform to examine the evolutionary dynamics under different conditions. Building on such understanding, we will develop and evaluate new treatment strategies that will exploit the evolutionary dynamics. It is our vision that the proposed research will have several broad impacts. First, it will fill the critical conceptual gap in our understandig of the evolution of programmed death. Second, it will generate novel insights into how bacteria respond to antibiotic-mediated stress, which has implications for designing novel therapeutic strategies against bacterial pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted control of self-transmissible plasmids by using engineered interfering plasmids
  • 批准号:
    10434929
  • 项目类别:
  • 资助金额:
    $36.48万
  • 财政年份:
    2021
  • 负责人:
    LINGCHONG YOU
  • 依托单位:
Targeted control of self-transmissible plasmids by using engineered interfering plasmids
  • 批准号:
    10277518
  • 项目类别:
  • 资助金额:
    $42.81万
  • 财政年份:
    2021
  • 负责人:
    LINGCHONG YOU
  • 依托单位:
Targeted control of self-transmissible plasmids by using engineered interfering plasmids
  • 批准号:
    10671458
  • 项目类别:
  • 资助金额:
    $36.48万
  • 财政年份:
    2021
  • 负责人:
    LINGCHONG YOU
  • 依托单位:
Tradeoffs between fitness costs and transfer rates in horizontal gene transfer
  • 批准号:
    10585969
  • 项目类别:
  • 资助金额:
    $42.92万
  • 财政年份:
    2017
  • 负责人:
    LINGCHONG YOU
  • 依托单位:
海外基金